NasdaqGM - Delayed Quote • USD
AC Immune SA (ACIU)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 7:19 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.15 | -0.22 | -0.73 | -0.23 |
Low Estimate | -0.22 | -0.23 | -0.77 | -0.55 |
High Estimate | -0.04 | -0.2 | -0.71 | 0.41 |
Year Ago EPS | -0.23 | -0.22 | -0.7 | -0.73 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 2 | 3 | 3 |
Avg. Estimate | 6.03M | 550k | 9.32M | 68.63M |
Low Estimate | -- | -- | -- | 27M |
High Estimate | 16.98M | 1.1M | 16.98M | 150.8M |
Year Ago Sales | -- | 1.84M | 16.24M | 9.32M |
Sales Growth (year/est) | -- | -70.10% | -42.60% | 636.40% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.25 | -0.21 | 0.03 | -0.12 |
EPS Actual | -0.23 | -0.22 | -0.21 | -0.05 |
Difference | 0.02 | -0.01 | -0.24 | 0.07 |
Surprise % | 8.00% | -4.80% | -800.00% | 58.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.15 | -0.22 | -0.73 | -0.23 |
7 Days Ago | -0.11 | -0.21 | -0.71 | -0.07 |
30 Days Ago | -0.11 | -0.21 | -0.71 | -0.08 |
60 Days Ago | -0.2 | -0.2 | -0.59 | -0.26 |
90 Days Ago | 0 | 0 | -0.56 | -0.31 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ACIU | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 34.80% | -- | -- | 0.40% |
Next Qtr. | 0.00% | -- | -- | 9.90% |
Current Year | -4.30% | -- | -- | 4.30% |
Next Year | 68.50% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/15/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/7/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 6/28/2023 |
Reiterates | HC Wainwright & Co.: Buy | 5/1/2023 |
Reiterates | HC Wainwright & Co.: Buy | 4/19/2023 |
Related Tickers
CGTX Cognition Therapeutics, Inc.
2.0000
+7.53%
ADAG Adagene Inc.
2.6500
0.00%
ALZN Alzamend Neuro, Inc.
0.7256
+5.47%
CBUS Cibus, Inc.
15.99
-0.06%
ATHA Athira Pharma, Inc.
2.0400
-2.39%
ASLN ASLAN Pharmaceuticals Limited
0.4690
+3.08%
ANVS Annovis Bio, Inc.
11.88
+3.39%
MNPR Monopar Therapeutics Inc.
0.6500
+2.85%
KRON Kronos Bio, Inc.
0.9500
-1.04%
DSGN Design Therapeutics, Inc.
3.6600
-5.91%